martes, 26 de mayo de 2015

Safety Alerts for Human Medical Products > SGLT2 inhibitors: Drug Safety Communication - FDA Warns Medicines May Result in a Serious Condition of Too Much Acid in the Blood

Safety Alerts for Human Medical Products > SGLT2 inhibitors: Drug Safety Communication - FDA Warns Medicines May Result in a Serious Condition of Too Much Acid in the Blood



National Guideline Clearinghouse (NGC)

U.S. Food and Drug Administration (FDA) Advisory

No hay comentarios:

Publicar un comentario